SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

8306	Companies
115295	Keywords
55580	Articles
62603	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/03/2024 at 22:15, 5 months 18 days ago

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3
Sarclisa in combo with VRd significantly enhances progression-free survival in newly diagnosed transplant-ineligible multiple myeloma in phase 3 study at ASCO. Full data published in NEJM

Multiple Myeloma Phase 3 Sarclisa Progression-free Survival VRd
BRIEF

published on 05/31/2024 at 12:05, 5 months 22 days ago

Sanofi Launches 2024 Global Employee Stock Purchase Plan

Financial Investment Sanofi Employee Stock Purchase Plan Action 2024 Global Participation
BRIEF

published on 05/31/2024 at 12:05, 5 months 22 days ago

Sanofi lance un plan mondial d'achat d'actions pour les salariés en 2024

Investissement Financier Sanofi Plan D'achat D'actions Pour Les Salariés Actions 2024 Participation Mondiale
PRESS RELEASE

published on 05/31/2024 at 12:00, 5 months 22 days ago

Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth

Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
PRESS RELEASE

published on 05/31/2024 at 12:00, 5 months 22 days ago

Communiqué de presse : Sanofi lance son plan mondial 2024 d’actionnariat salarié
Sanofi lance son plan mondial 2024 d'actionnariat salarié, ouvert à 80 000 salariés dans 56 pays, offrant actions à 72,87 € avec décote de 20%. Conditions et dates clés précisées pour la souscription

Actionnariat Salarié Souscription Sanofi Plan 2024 Entreprise De Santé
BRIEF

published on 05/31/2024 at 07:10, 5 months 22 days ago

Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO

Sanofi BPCO Dupixent CHMP Approvisionnement
BRIEF

published on 05/31/2024 at 07:10, 5 months 22 days ago

CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD

Sanofi COPD Dupixent CHMP Supply
PRESS RELEASE

published on 05/31/2024 at 07:05, 5 months 22 days ago

Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO
Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO. Dupixent deviendrait la première thérapie ciblée pour la BPCO en Europe

Traitement Approbation BPCO Dupixent CHMP
PRESS RELEASE

published on 05/31/2024 at 07:05, 5 months 22 days ago

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
European Medicines Agency's CHMP recommends Dupixent for EU approval to treat uncontrolled COPD with raised blood eosinophils. If approved, it would be the first targeted therapy for COPD in the EU

Dupixent CHMP EU Approval COPD Treatment Type 2 Inflammation
BRIEF

published on 05/30/2024 at 15:06, 5 months 22 days ago

Sanofi finalise l’acquisition d’Inhibrx, Inc.

Acquisition Sanofi Maladies Rares Inhibrx SAR447537

Accesswire

Published on 11/22/2024 at 14:45, 17 minutes ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 32 minutes ago

Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best
Published on 11/22/2024 at 14:20, 42 minutes ago

Plaintree Systems Inc. Announces Second Quarter Fiscal 2025 Results
Published on 11/22/2024 at 14:05, 57 minutes ago

First Gas-To-Power Data Centre Connection
Published on 11/22/2024 at 14:00, 1 hour 2 minutes ago

Clear Start Tax Warns Taxpayers About Upcoming IRS Collection Changes in 2025

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 14:46, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/22/2024 at 14:45, 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/22/2024 at 14:44, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Published on 11/22/2024 at 14:43, 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Published on 11/22/2024 at 14:42, 19 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc

Les Echos

Published on 11/22/2024 at 14:35, 26 minutes ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 26 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 8 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 8 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 8 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille

View all LES ECHOS COMFI WIRE